ANDASUBLINGUALTABLET
Approved
Sep 2010
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BUPRENORPHINE HYDROCHLORIDE (buprenorphine hydrochloride) by Teva is buprenorphine, a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor. Approved for opioid dependence. First approved in 2010.
Drug data last refreshed 18h ago
Mechanism of Action
buprenorphine, a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor.
Indications (1)
Company
Worked on BUPRENORPHINE HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.